159 related articles for article (PubMed ID: 22429966)
1. Aberrant calreticulin expression is involved in the dedifferentiation of dedifferentiated liposarcoma.
Hisaoka M; Matsuyama A; Nakamoto M
Am J Pathol; 2012 May; 180(5):2076-83. PubMed ID: 22429966
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-1 regulates adipogenesis: new insights in dedifferentiated liposarcoma tumorigenesis.
Zaragosi LE; Dadone B; Michiels JF; Marty M; Pedeutour F; Dani C; Bianchini L
Carcinogenesis; 2015 Jan; 36(1):32-40. PubMed ID: 25344834
[TBL] [Abstract][Full Text] [Related]
3. c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.
Snyder EL; Sandstrom DJ; Law K; Fiore C; Sicinska E; Brito J; Bailey D; Fletcher JA; Loda M; Rodig SJ; Dal Cin P; Fletcher CD
J Pathol; 2009 Jul; 218(3):292-300. PubMed ID: 19449367
[TBL] [Abstract][Full Text] [Related]
4. JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas.
Mariani O; Brennetot C; Coindre JM; Gruel N; Ganem C; Delattre O; Stern MH; Aurias A
Cancer Cell; 2007 Apr; 11(4):361-74. PubMed ID: 17418412
[TBL] [Abstract][Full Text] [Related]
5. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours.
Schneider-Stock R; Boltze C; Jäger V; Epplen J; Landt O; Peters B; Rys J; Roessner A
J Pathol; 2003 Apr; 199(4):517-25. PubMed ID: 12635143
[TBL] [Abstract][Full Text] [Related]
6. Significance of loss of heterozygosity of the RB1 gene during tumour progression in well-differentiated liposarcomas.
Schneider-Stock R; Boltze C; Jaeger V; Stumm M; Seiler C; Rys J; Schütze K; Roessner A
J Pathol; 2002 Aug; 197(5):654-60. PubMed ID: 12210086
[TBL] [Abstract][Full Text] [Related]
7. H-ras oncogene mutation in dedifferentiated liposarcoma. Polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M
Am J Clin Pathol; 2001 Feb; 115(2):235-42. PubMed ID: 11211612
[TBL] [Abstract][Full Text] [Related]
8. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma.
Fritz B; Schubert F; Wrobel G; Schwaenen C; Wessendorf S; Nessling M; Korz C; Rieker RJ; Montgomery K; Kucherlapati R; Mechtersheimer G; Eils R; Joos S; Lichter P
Cancer Res; 2002 Jun; 62(11):2993-8. PubMed ID: 12036902
[TBL] [Abstract][Full Text] [Related]
9. The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well-differentiated and dedifferentiated liposarcoma oncogenesis: an analysis of 104 tumors.
Louis-Brennetot C; Coindre JM; Ferreira C; Pérot G; Terrier P; Aurias A
Genes Chromosomes Cancer; 2011 Nov; 50(11):896-907. PubMed ID: 21910158
[TBL] [Abstract][Full Text] [Related]
10. Unique cell membrane expression of topoisomerase-II alpha as a useful diagnostic marker of liposarcoma.
Endo H; Hirokawa M; Ishimaru N; Tanaka Y; Yamashita M; Sakaki M; Hayashi Y; Sano T
Pathol Int; 2004 Mar; 54(3):145-50. PubMed ID: 14989736
[TBL] [Abstract][Full Text] [Related]
11. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.
Singer S; Socci ND; Ambrosini G; Sambol E; Decarolis P; Wu Y; O'Connor R; Maki R; Viale A; Sander C; Schwartz GK; Antonescu CR
Cancer Res; 2007 Jul; 67(14):6626-36. PubMed ID: 17638873
[TBL] [Abstract][Full Text] [Related]
13. Different mRNA expression profile during tumor progression in a well-differentiated liposarcoma--A microdissection approach.
Schneider-Stock R; Gerresheim F; Kolin-Gerresheim I; Meyer F; Jäger V; Epplen JT; Roessner A; Boltze C
Pathol Res Pract; 2003; 199(6):445-50. PubMed ID: 12924448
[TBL] [Abstract][Full Text] [Related]
14. [Dedifferentiated liposarcoma. A clinico-pathologic study of 6 cases].
Coindre JM; de Loynes B; Bui NB; Stockle E; de Mascarel I; Trojani M
Ann Pathol; 1992; 12(1):20-8. PubMed ID: 1580936
[TBL] [Abstract][Full Text] [Related]
15. Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features.
Lucas DR; Shukla A; Thomas DG; Patel RM; Kubat AJ; McHugh JB
Am J Surg Pathol; 2010 Jun; 34(6):844-51. PubMed ID: 20431481
[TBL] [Abstract][Full Text] [Related]
16. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.
Rodriguez R; Rubio R; Gutierrez-Aranda I; Melen GJ; Elosua C; García-Castro J; Menendez P
Stem Cells; 2011 Feb; 29(2):179-92. PubMed ID: 21732477
[TBL] [Abstract][Full Text] [Related]
17. Leptin and leptin receptor mRNA are widely expressed in tumors of adipocytic differentiation.
Oliveira AM; Nascimento AG; Lloyd RV
Mod Pathol; 2001 Jun; 14(6):549-55. PubMed ID: 11406655
[TBL] [Abstract][Full Text] [Related]
18. Liposarcoma of the oral and salivary gland region: a clinicopathologic study of 18 cases with emphasis on specific sites, morphologic subtypes, and clinical outcome.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2002 Oct; 15(10):1020-31. PubMed ID: 12379747
[TBL] [Abstract][Full Text] [Related]
19. Mature, adipocyte derived, dedifferentiated fat cells can differentiate into smooth muscle-like cells and contribute to bladder tissue regeneration.
Sakuma T; Matsumoto T; Kano K; Fukuda N; Obinata D; Yamaguchi K; Yoshida T; Takahashi S; Mugishima H
J Urol; 2009 Jul; 182(1):355-65. PubMed ID: 19457498
[TBL] [Abstract][Full Text] [Related]
20. Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of cytogenetic and molecular genetic analyses.
Benchetritt M; Hofman V; Vénissac N; Brennetot C; Italiano A; Aurias A; Padovani B; Pedeutour F; Hofman P
Cancer Genet Cytogenet; 2007 Dec; 179(2):150-5. PubMed ID: 18036404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
